substance use disorders | Department of Medicine Blog

Enhancing Trainee Knowledge and Competence in Addiction Medicine: Outcomes of an Interprofessional Addiction Consult Service Rotation

Goldman SA, Wurzburger R, Sokolski E, Lawrence D, Carney PA, Englander HL, Liu P. Enhancing Trainee Knowledge and Competence in Addiction Medicine: Outcomes of an[...]

By afschroeder • January 31, 2026

COVID-19 outcomes among individuals with substance use disorders

Chang CE, Knox D, Yu ZD, Shoaf K, Talboys SL, Hashibe M. COVID-19 outcomes among individuals with substance use disorders. Public Health. 2026 Jan 16;252:106156.[...]

By afschroeder • January 18, 2026

Unpacking the link between substance use disorders and 30-day unplanned readmission

Rosen AD, Takada S, Juillard C, Fernandez Montero YL, Richards AM, Ngekeng S, Shoptaw SJ, Bholat MA. Unpacking the link between substance use disorders and[...]

By afschroeder • July 24, 2025

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial

McKetin R, Degan TJ, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly PJ, Turner A, Clare PJ, Dean OM, Arunogiri[...]

By sjmartinez • June 22, 2024

Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021

Friedman J, Shover CL. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Addiction.[...]

By sjmartinez • September 14, 2023